DexCom (DXCM) PT Raised to $250 at Stifel, Top Diabetes Pick
Tweet Send to a Friend
Stifel analyst Mathew Blackman raised the price target on DexCom (NASDAQ: DXCM) to $250.00 (from $200.00) while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
